1. India Stocks

  2. •

    Process industries

  3. •

    Chemicals: specialty
Prolife Industries Ltd.

Prolife Industries Ltd.

NNSE:PROLIFE
79.80
INR
+3.80
(+5.00%)
901.31MMarket Cap
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
2026 Y
TTM
Revenue per Share
46.29
47.83
54.46
83.72
66.21
71.8
123.23
179.74
178.8
191.29
138.8
135.49
133.18
- -
Basic EPS, GAAP
0.54
0.99
1.28
2.71
3.68
4.97
9.87
13.43
10.51
16.89
21.4
11.43
10.39
- -
Free Cash Flow per Basic Share
0.58
-1.99
6.87
-8.96
6.77
-1.44
23
10.62
1.18
-2.63
39.54
-3.83
-6.26
- -
Dividend per Share
0.13
0.09
0.09
0.02
0.24
0.3
0.36
0.3
0.3
0.3
0.3
0.5
0.3
- -
Book Value per Share
6.2
7.38
8.77
21.21
24.64
29.62
39.12
52.25
62.46
79.04
100.14
111.07
121.16
111.07
Tangible Book Value per Share
6.2
7.38
8.77
21.21
24.64
29.62
39.12
52.25
62.46
79.04
100.14
111.07
121.16
111.07
Basic Weighted Avg Shares
4
4
4
3
4
4
4
4
4
4
4
4
4
4
Sales/Revenue/Turnover
190
196
223
270
271
294
505
736
732
783
568
555
545
- -
Operating Margin (%)
6.15
7.28
6.35
9.09
9.88
11.17
9.56
10.44
7.21
10.07
19.08
8.72
6.32
- -
Depreciation Expense
3
4
4
5
9
9
10
9
12
13
12
11
10
- -
Net Income, GAAP
2
4
5
9
15
20
40
55
43
69
88
47
43
- -
Effective Tax Rate (%)
44.8
35.45
35.43
34.01
28.05
27.92
28.93
25.6
27.96
25.13
26.11
25.96
27.44
- -
Profit Margin (%)
1.17
2.07
2.36
3.23
5.55
6.92
8.01
7.47
5.88
8.83
15.42
8.43
7.8
- -
Working Capital
52
52
28
58
29
61
27
26
53
138
261
281
325
281
LT Debt
93
87
68
67
57
83
53
45
49
41
38
26
3
26
Total Equity
25
30
36
87
101
121
160
214
256
324
410
455
496
455
Return on Invested Capital (%)
1.84
3.18
1.61
6.56
13.24
13.66
15.21
20.94
12.44
17.15
18.87
7.29
4.94
- -
Return on Capital (%)
5.86
8.68
8.9
10.87
14.38
15.57
20.87
23.21
16.22
22.4
22.78
10.61
8.82
- -
Return on Common Equity (%)
9.03
14.56
15.89
14.25
16.03
18.33
28.7
29.4
18.32
23.87
23.88
10.82
8.95
- -

Capital Structure

INR

•

in mil. unless spec.
Mar'24
Sep'25
Mar'25
ST Debt
- -
-62
- -
LT Borrowings
38
38
26
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
4
4
4
Market Capitalization
867
893
901

Working Capital

INR

•

in mil. unless spec.
Mar'24
Sep'25
Mar'25
Total Current Assets
327
215
327
Cash, Cash Equivalents & STI
216
2
174
Accounts Receivable, Net
54
112
85
Inventories
56
100
67
Total Current Liabilities
66
66
47
Payables & Accruals
- -
- -
- -
ST Debt
- -
-62
- -
Deferred Revenue
- -
- -
- -

Growth Rates

INR

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
33.67%
18.55%
9.08%
Free Cash Flow
-433.19%
-412.49%
63.63%
Net Income, GAAP
31.83%
2%
-9.07%
Sales/Revenue/Turnover
12.24%
-5.01%
-1.71%
Total Cash Common Dividend
- -
- -
-40.01%

Semi-annual Revenue

INR

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
568
2025
- -
- -
555
2026
- -
- -
545

Semi-annual Earnings Per Share

INR

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
21.4
2025
- -
- -
11.43
2026
- -
- -
10.39

Semi-annual Dividends Per Share

INR

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
0.3
2025
- -
- -
0.5
2026
- -
- -
0.3

Company Description

Company Profile APIChatGPT
Sector
Process industries
Industry
Chemicals: specialty
Address
Ankleshwar India
IPO Date
Jan 9, 2017
Website
prolifeindustries.in
Similar Companies
Petkim Petrokimya Holding Anonim Sirketi (BIST:PETKM)
Albemarle Corporation (NYSE:ALB)
Linde plc (NASDAQ:LIN)
Gubre Fabrikalari T.A.S. (BIST:GUBRF)
IOL Chemicals & Pharmaceuticals Ltd. (NSE:IOLCP)
Dow Inc. (NYSE:DOW)
Business
Prolife Industries Limited is an India-based specialty chemicals manufacturer engaged in the research, development, production, and commercialization of organic intermediates, dye intermediates, and fine chemical compounds for the dyes, pigments, pharmaceuticals, agrochemicals, and polymers industries. The company operates through a diversified product portfolio organized into key chemical categories: dye intermediates and naphthalene derivatives, including Dihydro Thio Para Toluidine Sulfonic Acid (DTPTSA), Amino Phenoxy Propane Sulfonic Acid (SPA), Amino Methyl Phenoxy Sulfonic Acid (SPMT), and Violet Acid; basic dyes and colorants, encompassing Basic Red, Basic Brown, Basic Yellow, and Basic Orange formulations; and high-purity organic and pharmaceutical intermediates, including 2-Chloro Methyl-3,4-Dimethoxy Pyridine, 5-Methoxy 6-Amino Benz Imidazole, Di Amino Bisphenoxy Ethane, Octahydro-4B-Methyl-9 (Methylamino), and PYBIZS. Prolife Industries caters to a business-to-business (B2B) clientele consisting of domestic and multinational chemical formulators, dye processors, and life-sciences manufacturers across India, while maintaining export operations to international markets including the United States, Germany, Spain, Switzerland, France, Japan, Taiwan, and Brazil. Founded in 1994 as Mamta Dyes and Intermediates Private Limited and later rebranded as Prolife Industries Limited in 2013, the company is headquartered in Ankleshwar, Gujarat, India, and operates manufacturing and research facilities in the Panoli Industrial Estate as a standalone enterprise without subsidiaries. In recent developments, the company has focused on modernizing process engineering and debottlenecking capacity across its Panoli production infrastructure, expanding its high-value specialty chemical pipeline tailored for pharmaceutical and agrochemical synthesis, strengthening international export distribution partnerships across European and American chemical supply chains, and integrating advanced environmental and quality-control standards across its production lines.